Unmet needs in the management of immune‐mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK—A modified‐Delphi study.
- Resource Type
- Article
- Source
- EJHaem; Aug2022, Vol. 3 Issue 3, p619-627, 9p
- Subject
- Language